Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
2.770
-0.230 (-7.67%)
At close: Nov 20, 2024, 4:00 PM
2.784
+0.014 (0.49%)
After-hours: Nov 20, 2024, 4:00 PM EST
Trevi Therapeutics Employees
Trevi Therapeutics had 25 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
25
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,772,680
Market Cap
212.92M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
High Tide | 1,550 |
SOPHiA GENETICS | 430 |
MacroGenics | 339 |
Editas Medicine | 265 |
Molecular Partners AG | 168 |
Genfit | 159 |
Zentalis Pharmaceuticals | 124 |
Orchestra BioMed Holdings | 56 |
TRVI News
- 1 hour ago - Trevi Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference - PRNewsWire
- 14 days ago - Trevi Therapeutics, Inc. (TRVI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Trevi Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates - PRNewsWire
- 21 days ago - Trevi Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on November 6, 2024 - PRNewsWire
- 4 weeks ago - Trevi Therapeutics Completes Enrollment for Phase 2a RIVER Trial in Refractory Chronic Cough - PRNewsWire
- 5 weeks ago - Trevi Therapeutics to Participate in Upcoming Commercial and Investor Conferences - PRNewsWire
- 6 weeks ago - Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program - PRNewsWire
- 7 weeks ago - Trevi Therapeutics Announces Appointment of James V. Cassella, Ph.D. - PRNewsWire